Technetium-99metastable ([99mTc]Tc) was adopted (with either MAG3 or HYNIC as chelators) obtaining excellent results in terms of bio-distribution, toxicity, dosimetry, target/background ratio and specific targeting ability to CD25 + cells in different autoimmune diseases and in melanoma patients [18–24]. Here, IL2RA is linked to autoimmune disease.